Skip to main content
OpenTrials

Clinical trial condition

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R

Explore clinical trials studying Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R trial results

Terminated

A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)

NCT05568225

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • Ocala Oncology Ocala, Florida, United States
  • NYU Langone Health New York, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details

Related conditions